{"metadata": {"source": "erowid", "title": "Erowid MDA Vault : Timeline", "description": "A timeline of events in the history of MDA", "language": "No language found.", "url": "https://www.erowid.org/chemicals/mda/mda_timeline.php", "drug": "MDA", "cid": 1614, "substance": "mda", "category": "CHEMICALS", "erowid_column": "History", "char_count": 8359, "word_count": 1239, "doc_id": "doc_168", "num_chunks": 11, "chunk_id": "168::chunk_4", "document_index": 168, "latency_s": 0.9381767000013497, "prompt_toks": 2599, "completion_toks": 78, "relevance_score": 9.952086e-07}, "content": "Drug: MDA | cid: 1614\nSource: erowid | Source description: A timeline of events in the history of MDA\nErowid name: mda\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    1910 MDA first synthesized by G. Mannish and W. Jacobson 1 1939 Animal tests are first performed with MDA. 1 1941 First human trials with MDA as part of an exploration of possible therapies for Parkinsonism. 2 1949-1957 MDA studied as a potential antidepressant and/or anorexic agent by Smith, Klein & French.  More than 500 people were given MDA during the course of this investigation. [More Info] Jan 8, 1953 Harold Blauer dies of an overdose of MDA (code name EA-1298) during an army-sponsored drug experiment.  The army was working to develop new \"truth serums\" or incapacitating agents and injected Blauer with 500 mg MDA IV. 3 [Details] [More Info] Blauer had checked himself into the New York State Psychiatric Institute for depression following his divorce.  Dr. James Cattell administered MDA injections to Harold Blauer, who died within two hours of his fifth and final injection. Edgewood Arsenal provided MDA to Dr. Cattell as part of a research program exploring the possible use of\n\n\n                    Context: \n                    This chunk provides a historical timeline of MDA, highlighting its synthesis in 1910, early animal and human trials, and its use in military experiments, including the 1953 overdose of Harold Blauer during an army-sponsored research program. It offers critical context for the document's detailed discussion of MDA's research, legal history, and effects within the broader exploration of psychoactive substances.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Ketamine Vault : Timeline", "description": "A timeline of events in the history of ketamine", "language": "No language found.", "url": "https://www.erowid.org/chemicals/ketamine/ketamine_timeline.php", "drug": "Ketamine", "cid": 3821, "substance": "ketamine", "category": "CHEMICALS", "erowid_column": "History", "char_count": 8811, "word_count": 1288, "doc_id": "doc_144", "num_chunks": 11, "chunk_id": "144::chunk_9", "document_index": 144, "latency_s": 0.8540087000001222, "prompt_toks": 2454, "completion_toks": 75, "relevance_score": 5.5391723e-07}, "content": "Drug: Ketamine | cid: 3821\nSource: erowid | Source description: A timeline of events in the history of ketamine\nErowid name: ketamine\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    for law enforcement purposes. 7 [Details] \"The American Society of Anesthesiologists firmly opposes the use of ketamine or any other sedative/hypnotic agent to chemically incapacitate someone for a law enforcement purpose and not for a legitimate medical reason. Ketamine is a potent analgesic, sedative and general anesthetic agent which can elevate blood pressure and heart rate, and can lead to confusion, agitation, delirium, and hallucinations. These effects can end in death when administered in a non-health care setting without appropriately trained medical personnel and necessary equipment.\"\n\n\n                    Context: \n                    This excerpt details the American Society of Anesthesiologists' official stance opposing the use of ketamine for law enforcement purposes, highlighting medical risks such as increased blood pressure, hallucinations, and potential death when used outside medical settings. It is part of the broader document on ketamine's history, effects, and legal status, emphasizing concerns about non-medical applications and safety.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Oxycodone Vault : Legal Status", "description": "Information on the legal status of Oxycodone.", "language": "No language found.", "url": "https://www.erowid.org/pharms/oxycodone/oxycodone_law.shtml", "drug": "Oxycodone", "cid": 5284603, "substance": "oxycodone", "category": "PHARMS", "erowid_column": "Law", "char_count": 5758, "word_count": 819, "doc_id": "doc_217", "num_chunks": 8, "chunk_id": "217::chunk_7", "document_index": 217, "latency_s": 0.7714528999931645, "prompt_toks": 1707, "completion_toks": 86, "relevance_score": 5.203571e-07}, "content": "Drug: Oxycodone | cid: 5284603\nSource: erowid | Source description: Information on the legal status of Oxycodone.\nErowid name: oxycodone\nCategory: PHARMS\nField: Law\n\n                    Text: \n                    Followup to \"Cruel and Unusual\" story, Nov 2007, NACDL\n\n[ back to pharms ] [ back to oxycodone ]\n\nCreated by Erowid - Oct 05, 2000 Modified - May 10, 2016\n\nContent & design © 1995-2023 Erowid.org. Permission required before publicly reproducing Erowid info.\n\n\n                    Context: \n                    This chunk provides a reference to a news follow-up titled \"Cruel and Unusual,\" published in November 2007 by NACDL, and includes navigation links back to related sections on pharmaceuticals and oxycodone within the Erowid legal information. It is relevant for users seeking legal or media context about opioid-related stories and is situated at the end of the detailed legal status section on oxycodone.\n                "}
